Doctors of Sir Ganga Ram Hospital in New Delhi have successfully treated patients
suffering from Covid-19 using monoclonal antibody therapy. The two
patients who were administered the REGCov2, designed to produce
resistance against the SARS-CoV-2, were discharged within 12 hours of
being given the doses.
Monoclonal antibodies are identical copies of an antibody that targets one specific antigen. This treatment has previously been used in treating deadly pathogens like Ebola and HIV. The REGCov2 is developed by Regeneron which is conducting the phase-3 Covid-19 prevention trials.
Dr Pooja Khosla, senior consultant, department of medicine, SGRH said that the two patients who were given the antibody were a 36-year-old healthcare worker, who was suffering from high-grade fever, cough, myalgia, severe weakness and low blood cell count, while the other was an 80-year man with comorbidities including diabetes and hypertension.
While Razdan's oxygen saturation was more than 95 per cent, a CT scan
confirmed the presence of mild Covid-19. The doctors administered
REGCov2 on both the patients, who showed a significant change in
parameters within the next 12 hours. Source :India Today .
No comments:
Post a Comment